Aldose reductase inhibitors: therapeutic implications for diabetic complications.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Expert Opinion on Investigational Drugs

• Publication date

  1999-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1517/13543784.8.12.2095PMID 11139842
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Binding of aldose reductase inhibitors: correlation of crystallographic and mass spectrometric studies

  1999cited by this paper
• Diabetic nephropathy is not associated with the dinucleotide repeat polymorphism upstream of the aldose reductase (ALR2) gene but with erythrocyte aldose reductase content in Japanese subjects with type 2 diabetes.

  1999cited by this paper
• Cataract formation through the polyol pathway is associated with free radical production.

  1999cited by this paper
• Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.

  1999cited by this paper
• Role for NADPH/NADH Oxidase in the Modulation of Vascular Tone a

  1999cited by this paper
• Diabetes complications and their potential prevention: Aldose reductase inhibition and other approaches

  1999cited by this paper
• Increased erythrocyte 3-DG and AGEs in diabetic hemodialysis patients: role of the polyol pathway.

  1999cited by this paper
• Aldose reductase, a key enzyme in the oxidative deamination of norepinephrine in rats.

  1999cited by this paper
• Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis.

  1999cited by this paper
• Renal proximal tubular cell fibronectin accumulation in response to glucose is polyol pathway dependent.

  1999cited by this paper
• Induction of rat aldose reductase gene transcription is mediated through the cis-element, osmotic response element (ORE): increased synthesis and/or activation by phosphorylation of ORE-binding protein is a key step.

  1999cited by this paper
• Osmoregulation in the mammalian kidney: the role of organic osmolytes.

  1999cited by this paper
• Contributions of polyol pathway to oxidative stress in diabetic cataract

  1999cited by this paper
• Attenuation of ischemia induced increases in sodium and calcium by the aldose reductase inhibitor zopolrestat.

  1999cited by this paper
• The role of aldose reductase gene in the susceptibility to diabetic nephropathy in Type II (non-insulin-dependent) diabetes mellitus (Short Communication)

  1999cited by this paper
• A novel polymorphism in the aldose reductase gene promoter region is strongly associated with diabetic retinopathy in adolescents with type 1 diabetes.

  1999cited by this paper
• Screening of Korean forest plants for rat lens aldose reductase inhibition.

  1999cited by this paper
• Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy

  1999cited by this paper
• Renal proximal tubular cell fibronectin accumulation in response to glucose is polyol pathway dependent

  1999cited by this paper
• The kinetics of translocation and cellular quantity of protein kinase C in human leukocytes are modified during spaceflight

  1999cited by this paper
• Potential Role of TGF-β in Diabetic Nephropathy

  1998cited by this paper
• Thiazolidinedione Exposure Increases the Expression of Uncoupling Protein 1 in Cultured Human Preadipocytes

  1998cited by this paper
• Molecular modeling studies of the binding modes of aldose reductase inhibitors at the active site of human aldose reductase.

  1998cited by this paper
• Effect of Aldose Reductase Inhibition on Heart Rate Variability in Patients with Severe or Moderate Diabetic Autonomic Neuropathy

  1998cited by this paper
• An aldose reductase inhibitor prevents glucose-induced increase in transforming growth factor-β and protein kinase C activity in cultured human mesangial cells

  1998cited by this paper
• A commentary on 10 years of aldose reductase inhibition for limited joint mobility in diabetes.

  1998cited by this paper
• Clinical analysis of aldose reductase for differential diagnosis of the pathogenesis of diabetic complication

  1998cited by this paper
• Increased NADH oxidase activity in the retina of the BBZ/Wor diabetic rat.

  1998cited by this paper
• Probing the inhibitor-binding site of aldose reductase with site-directed mutagenesis.

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Erythrocyte aldose reductase protein: a clue to elucidate risk factors for diabetic neuropathies independent of glycemic control.

  1998cited by this paper
• Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications.

  1998cited by this paper
• Administration of Ascorbic Acid and an Aldose Reductase Inhibitor (Tolrestat) in Diabetes: Effect on Urinary Albumin Excretion

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Reduction of 4-hydroxynonenal and 4-hydroxyhexenal by retinal aldose reductase.

  1998cited by this paper
• Influence of Interindividual Variability of Aldose Reductase Protein Content on Polyol-Pathway Metabolites and Redox State in Erythrocytes in Diabetic Patients

  1998cited by this paper
• High glucose-induced mesangial cell altered contractility: role of the polyol pathway

  1998cited by this paper
• Depletion of Phospholipid Arachidonoyl‐Containing Molecular Species in a Human Schwann Cell Line Grown in Elevated Glucose and Their Restoration by an Aldose Reductase Inhibitor

  1998cited by this paper
• Future prevention and treatment of diabetic neuropathy.

  1998cited by this paper
• Catalytic mechanism of aldose reductase studied by the combined potentials of quantum mechanics and molecular mechanics.

  1998cited by this paper
• Susceptibility to diabetic neuropathy in patients with insulin dependent diabetes mellitus is associated with a polymorphism at the 5′ end of the aldose reductase gene

  1998cited by this paper
• Therapeutic effects of aldose reductase inhibitor on experimental diabetic neuropathy through synthesis/secretion of nerve growth factor.

  1998cited by this paper
• Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group.

  1998cited by this paper
• Potential role of TGF-beta in diabetic nephropathy.

  1998cited by this paper
• An aldose reductase inhibitor prevents glucose-induced increase in transforming growth factor-beta and protein kinase C activity in cultured mesangial cells.

  1998cited by this paper
• Protein kinase C activation and the development of diabetic complications.

  1998cited by this paper
• Aldose reductase: a window to the treatment of diabetic complications?

  1998cited by this paper
• An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia.

  1997cited by this paper
• Glycolytic pathway, redox state of NAD(P)-couples and energy metabolism in lens in galactose-fed rats: effect of an aldose reductase inhibitor.

  1997cited by this paper
• Identification of a Novel cis-Element Required for the Constitutive Activity and Osmotic Response of the Rat Aldose Reductase Promoter*

  1997cited by this paper
• Effects of aldehyde/aldose reductase inhibition on neuronal metabolism of norepinephrine.

  1997cited by this paper
• Aldose Reductase Inhibition Increases CNTF-Like Bioactivity and Protein in Sciatic Nerves From Galactose-Fed and Normal Rats

  1997cited by this paper
• Aldose Reductase Inhibition Protects Diabetic and Nondiabetic Rat Hearts from Ischemic Injury

  1997cited by this paper
• Regulation of gene expression by hypertonicity.

  1997cited by this paper
• Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor.

  1997cited by this paper
• A new nomenclature for the aldo-keto reductase superfamily.

  1997cited by this paper
• Effect of inhibition of aldose reductase on glucose flux, diacylglycerol formation, protein kinase C, and phospholipase A2 activation.

  1997cited by this paper
• Identification and Characterization of Multiple Osmotic Response Sequences in the Human Aldose Reductase Gene*

  1997cited by this paper
• Polymorphism in the 5′-End of the Aldose Reductase Gene Is Strongly Associated With the Development of Diabetic Nephropathy in Type I Diabetes

  1997cited by this paper
• Polyol pathway activation and glutathione redox status in non-insulin-dependent diabetic patients.

  1997cited by this paper
• The level of erythrocyte aldose reductase: a risk factor for diabetic neuropathy?

  1997cited by this paper
• A potential role for aldose reductase in steroid metabolism.

  1997cited by this paper
• The polyol pathway—a culprit in diabetic neuropathy?

  1997cited by this paper
• Metabolic and Vascular Factors in the Pathogenesis of Diabetic Neuropathy

  1997cited by this paper
• The alrestatin double-decker: binding of two inhibitor molecules to human aldose reductase reveals a new specificity determinant.

  1997cited by this paper
• Mesangial cell actin disassembly in high glucose mediated by protein kinase C and the polyol pathway.

  1997cited by this paper
• Pancreas Transplantation Restores Epinephrine Response and Symptom Recognition During Hypoglycemia in Patients With Long-Standing Type I Diabetes and Autonomic Neuropathy

  1997cited by this paper
• Glucose-specific regulation of aldose reductase in capan-1 human pancreatic duct cells In vitro.

  1997cited by this paper
• Active site modification of aldose reductase by nitric oxide donors.

  1997cited by this paper
• A 'specificity' pocket inferred from the crystal structures of the complexes of aldose reductase with the pharmaceutically important inhibitors tolrestat and sorbinil.

  1997cited by this paper
• Isolation of the Mouse Aldose Reductase Promoter and Identification of a Tonicity-responsive Element*

  1997cited by this paper
• A PERSPECTIVE OF ALDOSE REDUCTASE INHIBITORS AND DIABETIC COMPLICATIONS

  1996cited by this paper
• Zopolrestat prevention of proteinuria, albuminuria and cataractogenesis in diabetes mellitus.

  1996cited by this paper
• The cellular and molecular mechanisms of diabetic complications.

  1996cited by this paper
• Familial factors determine the development of diabetic nephropathy in patients with IDDM

  1996cited by this paper
• Prevention of early glomerulopathy with tolrestat in the streptozotocin-induced diabetic rat.

  1996cited by this paper
• Influence of aldose reductase inhibition on the microvascular reactivity in experimental diabetes.

  1996cited by this paper
• Galactosemic Neuropathy in Transgenic Mice for Human Aldose Reductase

  1996cited by this paper
• Effect of an aldose reductase inhibitor on type IV collagen production by human endothelial cells cultured in high glucose

  1996cited by this paper
• The Pathophysiology of Diabetic Complications: How Much Does the Glucose Hypothesis Explain?

  1996cited by this paper
• Interactions between essential fatty acid, prostanoid, polyol pathway and nitric oxide mechanisms in the neurovascular deficit of diabetic rats

  1996cited by this paper
• Increased levels of methylglyoxal-metabolizing enzymes in mononuclear and polymorphonuclear cells from insulin-dependent diabetic patients with diabetic complications: aldose reductase, glyoxalase I, and glyoxalase II--a clinical research center study.

  1996cited by this paper
• Increased white cell aldose reductase mRNA levels in diabetic patients.

  1996cited by this paper
• Oxidized aldose reductase: in vivo factor not in vitro artifact.

  1996cited by this paper
• Kinetic and spectroscopic evidence for active site inhibition of human aldose reductase.

  1996cited by this paper
• Aldose reductase is a major reductase for isocaproaldehyde, a product of side-chain cleavage of cholesterol, in human and animal adrenal glands.

  1996cited by this paper
• Reversal of defective peripheral nerve conduction velocity, nutritive endoneurial blood flow, and oxygenation by a novel aldose reductase inhibitor, WAY-121,509, in streptozotocin-induced diabetic rats.

  1996cited by this paper
• Chromosome 7q35 and susceptibility to diabetic microvascular complications.

  1996cited by this paper
• ORE, a Eukaryotic Minimal Essential Osmotic Response Element

  1996cited by this paper
• Rapid formation of advanced glycation end products by intermediate metabolites of glycolytic pathway and polyol pathway.

  1996cited by this paper
• An (A-C)n dinucleotide repeat polymorphic marker at the 5' end of the aldose reductase gene is associated with early-onset diabetic retinopathy in NIDDM patients.

  1995cited by this paper
• The pathological implications of protein glycation.

  1995cited by this paper
• Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens.

  1995cited by this paper
• Tyrosine-48 is the proton donor and histidine-110 directs substrate stereochemical selectivity in the reduction reaction of human aldose reductase: enzyme kinetics and crystal structure of the Y48H mutant enzyme.

  1994cited by this paper
• Aldose Reductase Catalysis and Crystallography: Insights From Recent Advances in Enzyme Structure and Function

  1994cited by this paper
• High levels of erythrocyte aldose reductase and diabetic retinopathy in NIDDM patients

  1994cited by this paper
• Aldose reductase inhibition, nerve perfusion, oxygenation and function in streptozotocin-diabetic rats: Dose-response considerations and independence from a myo-inositol mechanism

  1994cited by this paper
• Diabetic nephropathy, renal hemodynamics, and aldose reductase inhibitors

  1994cited by this paper
• An anion binding site in human aldose reductase: mechanistic implications for the binding of citrate, cacodylate, and glucose 6-phosphate.

  1994cited by this paper
• Hyperglycemic Pseudohypoxia and Diabetic Complications

  1993cited by this paper

• Novel flavone derivatives as aldose reductase inhibitors with anti-cataract potential using goat lens

  2026cites this paper
• Exploration of antidiabetic properties of a xanthene derivative, RH by targeting aldose reductase: In Silico studies

  2026cites this paper
• Parallelism and non-parallelism in diabetic nephropathy and diabetic retinopathy

  2024cites this paper
• SORDD: mutation frequency and phenotype in predominantly axonal Charcot-Marie-Tooth disease of undefined genetic cause

  2024cites this paper
• Hepatic aldose reductase drives a Warburg effect-like metabolic reprogramming to promote insulin resistance, fatty liver and obesity

  2024cites this paper
• Novel acetic acid derivatives containing quinazolin‐4(3H)‐one ring: Synthesis, in vitro, and in silico evaluation of potent aldose reductase inhibitors

  2023influential citation
• Benzothiazole Analogues: As Aldose Reductase Inhibitor (ARIs) for the Management of Diabetic Neuropathy and Cardiomyopathy

  2023cites this paper
• Composition of the gut microbiome, role of diet, lifestyle, and antioxidant therapies in diabetes mellitus and diabetic retinopathy

  2023cites this paper
• “CORRELATION BETWEEN OXIDATIVE STRESS MARKERS AND DIABETIC CATARACT”

  2022cites this paper
• Perilla frutescens (Linn.) Britt Leaves Extract Mediated Green Synthesis, Characterization, In Vitro Biological Activities and Embryo Toxicity of Copper Nanoparticles

  2022cites this paper
• Pain Allaying Epalrestat-Loaded Lipid Nanoformulation for the Diabetic Neuropathic Pain Interventions: Design, Development and Animal Study.

  2022cites this paper
• Perilla frutescens: A Rich Source of Pharmacological Active Compounds

  2022cites this paper
• Type 2 Diabetes Contributes to Altered Adaptive Immune Responses and Vascular Inflammation in Patients With SARS-CoV-2 Infection

  2022cites this paper
• CADD Studies in the Discovery of Potential ARI (Aldose Reductase Inhibitors) Agents for the Treatment of Diabetic Complications.

  2022cites this paper
• Utilization of Gelling Polymer to Formulate Nanoparticles Loaded with Epalrestat-Cyclodextrin Inclusion Complex: Formulation, Characterization, In-Silico Modelling and In-Vivo Toxicity Evaluation

  2021cites this paper
• An extensive research on aldose reductase inhibitory effects of new 4H-1,2,4-triazole derivatives

  2021cites this paper
• Determination of Afzelin and Astragalin from Lespedeza cuneata on Aldose Reductase Inhibition.

  2021cites this paper
• Phytosynthesis of Silver Nanoparticles Using Perilla frutescens Leaf Extract: Characterization and Evaluation of Antibacterial, Antioxidant, and Anticancer Activities

  2021cites this paper
• Aldose Reductase: An Emerging Target for Development of Interventions for Diabetic Cardiovascular Complications

  2021cites this paper
• Therapeutic application of nutraceuticals in diabetic nephropathy: Current evidence and future implications

  2020cites this paper
• Current molecular aspects in the development and treatment of diabetes

  2020cites this paper
• An insight into the synthesis and SAR of 2,4-thiazolidinediones (2,4-TZD) as multifunctional scaffold: A review.

  2020cites this paper
• Association of oxidative stress with the bone turnover in pre and post menopausal diabetic women

  2020cites this paper
• Natural Compounds as Source of Aldose Reductase (AR) Inhibitors for the Treatment of Diabetic Complications: A Mini Review.

  2020cites this paper
• Dihydrobenzoxazinone derivatives as aldose reductase inhibitors with antioxidant activity.

  2020cites this paper
• Understanding Aldose Reductase-Inhibitors interactions with free energy simulation.

  2019cites this paper
• Identification of quinoxalin-2(1H)-one derivatives as a novel class of multifunctional aldose reductase inhibitors.

  2019cites this paper
• Aldose reductase inhibitors: 2013-present

  2019cites this paper
• Forskolin alleviates diabetic nephropathy via inhibition of aldose reductase and advanced glycation end products formation

  2019cites this paper
• Integrated Metabolomic and Transcriptomic Profiling Reveals Novel Activation-Induced Metabolic Networks in Human T cells

  2019cites this paper
• Polyphenols of marine red macroalga Symphyocladia latiuscula ameliorate diabetic peripheral neuropathy in experimental animals

  2019cites this paper
• Coumarin tethered cyclic imides as efficacious glucose uptake agents and investigation of hit candidate to probe its binding mechanism with human serum albumin.

  2019cites this paper
• Contribution of Aldose Reductase-Mediated Oxidative Stress Signaling in Inflammatory Lung Diseases

  2019cites this paper
• Vitamin K1 prevents diabetic cataract by inhibiting lens aldose reductase 2 (ALR2) activity

  2019cites this paper
• Antidiabetic plant-derived nutraceuticals: a critical review

  2018cites this paper
• Inhibitory effects of Synurus excelsus and Weigela subsessilis on aldose reductase and HPLC-UV analysis of scopolin, scopoletin, and quercetin

  2018cites this paper
• Human Aldose Reductase Expression Prevents Atherosclerosis Regression in Diabetic Mice

  2018cites this paper
• Oxidative Stress , Antioxidants and Saliva : A Review

  2018cites this paper
• Panvascular risk factor – Diabetes

  2018cites this paper
• Enhanced dissolution and solubility of Epalrestat with β-Cyclodextrin ternary complex using Arginine

  2018cites this paper
• Synthesis and structure-activity relationship studies of phenolic hydroxyl derivatives based on quinoxalinone as aldose reductase inhibitors with antioxidant activity.

  2017cites this paper
• Novel quinazolinone-based 2,4-thiazolidinedione-3-acetic acid derivatives as potent aldose reductase inhibitors.

  2017cites this paper
• Structure based comprehensive modelling, spatial fingerprints mapping and ADME screening of curcumin analogues as novel ALR2 inhibitors

  2017cites this paper
• Enhanced dissolution and skin permeation profiles of epalrestat with &bgr;‐cyclodextrin derivatives using a cogrinding method

  2017cites this paper
• Competitive binding experiments can reduce the false positive results of affinity-based ultrafiltration-HPLC: A case study for identification of potent xanthine oxidase inhibitors from Perilla frutescens extract.

  2017cites this paper
• Quinazolinone-based rhodanine-3-acetic acids as potent aldose reductase inhibitors: Synthesis, functional evaluation and molecular modeling study.

  2017cites this paper
• In vitro and in vivo inhibition of aldose reductase and advanced glycation end products by phloretin, epigallocatechin 3-gallate and [6]-gingerol.

  2016cites this paper
• Oxidative stress of crystalline lens in rat menopausal model.

  2016cites this paper
• Investigation of synergistic mechanism and identification of interaction site of aldose reductase with the combination of gigantol and syringic acid for prevention of diabetic cataract

  2016cites this paper
• PROTECTIVE EFFECT OF SAPONIN OF MOMORDICA CYMBALARIA FENZL ON HIGH-GLUCOSE INDUCED NEUROPATHY IN NB-41A3 MOUSE NEUROBLASTOMA CELLS

  2016cites this paper
• Aldose reductase, ocular diabetic complications and the development of topical Kinostat(®).

  2016cites this paper
• Diabetic complications within the context of aging: Nicotinamide adenine dinucleotide redox, insulin C‐peptide, sirtuin 1–liver kinase B1–adenosine monophosphate‐activated protein kinase positive feedback and forkhead box O3

  2016cites this paper
• The Effects of the Wild African Potato (Hypoxis hemerocallidea)Supplementation on Streptozotocin-Induced Diabetic Wistar Rats ReproductiveFunction

  2016cites this paper
• Pathogenesis of Microvascular Complications

  2016cites this paper
• Pterostilbene alleviates diabetic nephropathy in experimental diabetic rats; inhibition of aldose reductase and advanced glycation end products formation

  2015cites this paper
• Olanzapine inhibits body weight gain in male Wistar rats, which is amplified by adjunctive Topiramate treatment; hepatic proteome analysis points towards a disruption in growth hormone regulation

  2015cites this paper
• The inhibitory effect of Isoflavones isolated from Caesalpinia pulcherrima on aldose reductase in STZ induced diabetic rats.

  2015cites this paper
• Targeting aldose reductase for the treatment of diabetes complications and inflammatory diseases: new insights and future directions.

  2015cites this paper
• Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss

  2015cites this paper
• Bridging Between Disease, Prevalence and Treatment of Diabetes Mellitus : A Review

  2015cites this paper
• Chapter 5 – Organofluorine Pharmaceuticals

  2015cites this paper
• Design and synthesis of potent and multifunctional aldose reductase inhibitors based on quinoxalinones.

  2015cites this paper
• The atypical effects of olanzapine on body weight regulation

  2015cites this paper
• Ameliorative potentials of medicinal plants on the pathophysiological complications of diabetes mellitus: A review

  2015cites this paper
• Novel insights into the mechanisms whereby isoflavones protect against fatty liver disease.

  2015cites this paper
• Fungal metabolite nigerloxin ameliorates diabetic nephropathy and gentamicin-induced renal oxidative stress in experimental rats

  2014cites this paper
• Tonicity-responsive enhancer binding protein regulates the expression of aldose reductase and protein kinase C δ in a mouse model of diabetic retinopathy.

  2014cites this paper
• The effects of HIV Protease Inhibitors (Lopinavir/Ritonavir) on the non-oxidative pathways of glucose metabolism

  2014cites this paper
• Preparative isolation of aldose reductase inhibitory compounds from Nardostachys chinensis by elution–extrusion counter-current chromatography

  2014cites this paper
• Production sélective et directionnelle des prostaglandines dans l'endomètre

  2014cites this paper
• Aldose reductase regulates miR-200a-3p/141-3p to coordinate Keap1-Nrf2, Tgfβ1/2, and Zeb1/2 signaling in renal mesangial cells and the renal cortex of diabetic mice.

  2014cites this paper
• Plants Used in the Management of Diabetic Complications

  2014cites this paper
• Molecular Mechanisms of Diabetic Retinopathy, General Preventive Strategies, and Novel Therapeutic Targets

  2014cites this paper
• Inhibition of sorbitol dehydrogenase by nucleosides and nucleotides.

  2013cites this paper
• LC-MS/MS method for the quantification of aldose reductase inhibitor-epalrestat and application to pharmacokinetic study.

  2013cites this paper
• Rapid Identification of Aldose Reductase Inhibitory Compounds from Perilla frutescens

  2013cites this paper
• Hypertensive cardiac remodeling effects of lignan extracts from Eucommia ulmoides Oliv. bark--a famous traditional Chinese medicine.

  2013cites this paper
• Molecular Docking Analysis of Sorbitol Dehydrogenase Using Ligandfit Algorithm

  2013cites this paper
• Pathophysiology of Diabetic Retinopathy

  2013cites this paper
• Aldose reductase inhibitors and nanodelivery of diabetic therapeutics.

  2012cites this paper
• The Isolation and Characterization of β-Glucogallin as a Novel Aldose Reductase Inhibitor from Emblica officinalis

  2012cites this paper
• Proteomics and Systems Biology for Understanding Diabetic Nephropathy

  2012cites this paper
• Inhibition of Aldose Reductase by Gentiana lutea Extracts

  2012cites this paper
• Aldose Reductase, Oxidative Stress, and Diabetic Mellitus

  2012cites this paper
• Benzofuroxane derivatives as multi-effective agents for the treatment of cardiovascular diabetic complications. Synthesis, functional evaluation, and molecular modeling studies.

  2012cites this paper
• Development and validation of a rapid high-performance liquid chromatography-tandem mass spectrometry method for the determination of WJ-38, a novel aldose reductase inhibitor, in rat plasma and its application to a pharmacokinetic study.

  2012cites this paper
• Retinopathy in diabetes.

  2012cites this paper
• Diabetes, Oxidative Stress, Antioxidants and Saliva: A Review

  2012cites this paper
• Beneficial influence of fungal metabolite nigerloxin on eye lens abnormalities in experimental diabetes.

  2012cites this paper
• Pharmacologically tested aldose reductase inhibitors isolated from plant sources-A concise report

  2012cites this paper
• Novel Pharmacological Approaches to the Treatment of Type 2 Diabetes

  2012cites this paper
• ROLE OF OXIDATIVE STRESS IPATHOGEESIS OF DIABETES AD ITS COMPLICATIOS

  2011cites this paper
• Genetic deficiency of aldose reductase counteracts the development of diabetic nephropathy in C57BL/6 mice

  2011cites this paper
• Inhibition of Aldose Reductase Activates Hepatic Peroxisome Proliferator-Activated Receptor-α and Ameliorates Hepatosteatosis in Diabetic db/db Mice

  2011cites this paper
• Nitric Oxide/Reactive Oxygen Species Generation and Nitroso/Redox Imbalance in Heart Failure: From Molecular Mechanisms to Therapeutic Implications

  2011cites this paper
• Inhibitory effects of chlorogenic acid on aldose reductase activity in vitro and cataractogenesis in galactose-fed rats

  2011cites this paper
• Diabetic retinopathy, superoxide damage and antioxidants.

  2011cites this paper
• ROLE OF OXIDATIVE STRESS I PATHOGE ESIS OF DIABETES A D ITS COMPLICATIO S

  2011cites this paper
• Diabetes and Nonalcoholic Fatty Liver Disease

  2011cites this paper
• Altered Retinoic Acid Metabolism in Diabetic Mouse Kidney Identified by 18O Isotopic Labeling and 2D Mass Spectrometry

  2010cites this paper